Table 4.
None–mild NPDR | Moderate–severe NPDR
|
PDR
|
|||||||
---|---|---|---|---|---|---|---|---|---|
ETDRS field | Crude mean perfusion |
Crude mean perfusion |
Estimates | p Value | Adjusted p value |
Crude mean perfusion |
Estimates | p Value | Adjusted p value |
Central foveal | 1.57 | 1.45 | −0.058 | 0.818 | 1.000 | 1.17 | −0.323 | 0.258 | 1.000 |
Inner inferior | 39.52 | 36.31 | −3.849 | 0.038* | 0.343 | 31.81 | −7.802 | <0.001* | 0.004* |
Inner nasal | 38.99 | 35.78 | −3.523 | 0.070 | 0.629 | 32.32 | −5.978 | 0.007* | 0.066 |
Inner superior | 39.25 | 35.44 | −4.031 | 0.008* | 0.071 | 32.86 | −6.346 | <0.001* | 0.003* |
Inner temporal | 39.91 | 34.80 | −5.216 | 0.010* | 0.093 | 32.36 | −6.787 | 0.003* | 0.031* |
Outer inferior | 41.74 | 39.94 | −1.619 | 0.284 | 1.000 | 37.68 | −3.076 | 0.073 | 0.655 |
Outer nasal | 39.38 | 38.99 | −1.275 | 0.492 | 1.000 | 38.42 | −0.860 | 0.678 | 6.102 |
Outer superior | 40.13 | 39.76 | −0.452 | 0.719 | 1.000 | 39.81 | 0.243 | 0.862 | 7.758 |
Outer temporal | 41.62 | 39.20 | −2.179 | 0.129 | 1.000 | 37.88 | −2.370 | 0.141 | 1.269 |
p Values <0.05.
BCVA, best-corrected visual acuity; DM, diabetes mellitus; HLD, hyperlipidaemia; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.